Fat Quality and Postprandial Inflammation (PI:fat)

February 26, 2024 updated by: Göteborg University

Impact of Fat Quality on Postprandial Inflammation (PI:Fat): a Randomized Controlled Trial

This aim of this randomized controlled postprandial study is to compare the effects of four different far sources (butter, coconut, corn oil and flax seed oil) on postprandial inflammation and metabolic response.

The main questions it aims to answer are:

  1. What is the impact of different dietary sources of saturated and polyunsaturated fatty acids on postprandial inflammation?
  2. Is the impact of different dietary sources of saturated and polyunsaturated fatty acids on postprandial inflammation mediated by glucose or blood lipids?
  3. Can postprandial inflammatory or metabolic response be predicted by individual factors at baseline?

Participants will consume four meals, identical except for the fat source, in random order and sampled for blood and urine for up to 6 hours.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

A randomized crossover single meal study will be conducted, comparing four isocaloric meals. The study will be carried out at two sites; one study center is located in Gothenburg, Sweden (Department of Internal Medicine and Clinical Nutrition at the University of Gothenburg) and one study center in Oslo, Norway (Department of Nutrition, University of Oslo).

A total of 20 healthy adults will be recruited and consume four meals, identical except for the fat source, in random order and sampled for blood and urine for up to 6 hours after. Each of the four meals will be separated by a 1 month washout. Subjects will be asked to abstain from rigorous physical activity, alcohol and high-fat foods the day prior to their test meal days.

Four isocaloric high-fat meals with different fatty acid profiles will be compared:

  1. butter
  2. coconut oil
  3. corn oil
  4. flax seed oil

At test meal days, study outcomes will be assessed at baseline (0h, fasting, pre meal), 30 min, 1h, 2h, 4h and at 6h (endpoint). At these timepoints, blood pressure will be measured and blood glucose sampled through capillary blood. At baseline, 2h, 4h and 6h, blood will be drawn by venipuncture. Urine will be collected when the participants need to void.

Blood will be collected and handled according to a standardized protocol to prevent any degradation, before stored in -80°C until analysis. At baseline and endpoint, peripheral blood mononuclear cells from blood samples will be isolated using cell preparation tubes and stored at -80 °C until RNA isolation. Lipids, lipoprotein profile and inflammation markers (e.g. cytokines, chemokines, endothelial factors) will be analyzed in samples from 0, 2, 4 and 6 hours.

Differences between meals in the outcomes will be compared using area under the curve and mixed models effect.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Göteborg, Sweden
        • University of Gothenburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • BMI >18.5
  • Willingness to eat study meals

Exclusion Criteria:

  • Diabetes
  • Cardiovascular disease
  • Cancer
  • Dyslipidemia
  • Anemia (Hb <100)
  • Habitual intake of anti-inflammatory drugs
  • Recent weight change (>±5%)
  • Pregnancy, lactation
  • Current smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Butter
Butter based meal
Four different sources of dietary fat
Active Comparator: Coconut
Coconut based meal
Four different sources of dietary fat
Active Comparator: Corn oil
Corn oil based meal
Four different sources of dietary fat
Active Comparator: Flax seed oil
Flax seed oil based meal
Four different sources of dietary fat

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inflammation markers
Time Frame: 0, 2, 4 and 6 hours
Cytokines, chemokines, endothelial factors
0, 2, 4 and 6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lipoproteins
Time Frame: 0, 2, 4 and 6 hours
Triglycerides, VLDL
0, 2, 4 and 6 hours
Lipidomics
Time Frame: 0, 2, 4 and 6 hours
Lipidomics characterization of lipid classes
0, 2, 4 and 6 hours
Blood glucose
Time Frame: 0, 0.5, 1, 2, 4, 6 hours
Capillary glucose sampling
0, 0.5, 1, 2, 4, 6 hours
Blood pressure
Time Frame: 0, 0.5, 1, 2, 4, 6 hours
Systolic and diastolic
0, 0.5, 1, 2, 4, 6 hours
Gene expression
Time Frame: 0 and 4 hours
Gene expression in peripheral blood mononuclear cells in a subset (N=10) participants
0 and 4 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Linnea Bärebring, PhD, Göteborg University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2023

Primary Completion (Actual)

January 23, 2024

Study Completion (Actual)

January 23, 2024

Study Registration Dates

First Submitted

January 3, 2023

First Submitted That Met QC Criteria

January 5, 2023

First Posted (Actual)

January 6, 2023

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 26, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-05898-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

Clinical Trials on Fat intake

3
Subscribe